Read on Twitter
1/11 THE LANCET #HYDROXYCHLOROQUINE STUDY: CONFLICT OF INTERESTS? This observational cohort study was signed by 4 cardiologists , not a virologist, epidemiologist or statistician signed the study. But let´s see who they are: 1. MD Mandeep Mehra: Chief Cardiologist in the...
2/11 ....Brigham and Women´s hospital in Boston. This hospital has been running since march two clinical trials on Remdesevir, under contract by Gilead, an antiviral drug that could be directly affected by unpatented and low cost Hydroxychloroquine. 2. https://www.brighamhealthonamission.org/2020/03/26/two-remdesivir-clinical-trials-underway-at-brigham-and-womens-hospital/
3/11 MD Mehra also participated in a symposium COVID19 hosted by SEIMC (Barcelona) and sponsored by Gilead. He was one of the conference speakers.
https://asscat-hepatitis.org/coronavirus-gilead-y-seimc-forman-a-mas-de-8-000-profesionales/#
https://asscat-hepatitis.org/coronavirus-gilead-y-seimc-forman-a-mas-de-8-000-profesionales/#
4/11 One of the companies involved in the financing in this study was the swiss Roivant, manufacturer of Gimsilumab, a monoclonal antibody that it´s been tested against #Covid19. Again MD Mandeep Mehra, a cardiologist giving an opinion in areas out of his speciality.....
5/11 ...said about this new drug: "GM-CSF-targeted immunomodulation to address the aberrant host immune response in Covid-19 appears promising for reducing lung injury and death in this aggressive illness." https://www.clinicaltrialsarena.com/news/roivant-gimsilumab-covid-19-trial/
6/11 2. Frank Ruschitzka, a cardiologist that works for the University of Zurich. In 2010 their heart center tested Darusentan, produced by Gilead. And more: Gilead appears to be a regular financier at the University of Zurich, as Gileads page indicates: https://www.gilead.com/utility/global-operations/europe/switzerland/historical-support
7/11 3. MD Amit N Patel: just signed a study on the effectiveness of Ivermectin produced by Merck (Stromectol), in the fight against coronavirus. This study observational and cohort also signed by.. Guess who? Yes.. Mandeep Mehra and Sapan S Desai.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3580524
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3580524
8/11 4. MD Sapan S Desai, is the head of a Chicago based health company called Surgisphere, which produces tests to screen for coronavirus. This company also claims to have processed the huge amount of data of 96000 patients of multiple countries and languages in about a month.
9/11 ... "In fact, these are simple Javascript exercises without any health care value. But they accept input and give output, and a user might be deceived to believe that they provide functionality" described in the Surgisphere’s press releases and other promotional materials.
10/11 Other sponsors: ABBOTT labs: selling rapid test machines for Covid19. MEDTRONIC: Sells ICU ventilators. JANSEEN: Antiviral Darunavir and Vaccine. MESOBLAST: Manufacturer of Remestemcel, in trials against Covid19. PORTOLA: Manufactures Andexxa (coagulation factor).
11/11 "Funding: William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital". Yes the Hospital under contract with Gilead where MD Mandeep Mehra works. END
